Study of zilebesiran for high-risk hypertension patients
Part of Heart & circulation clinical trials.
This trial tests a new medicine called zilebesiran for people with high blood pressure that isn't well controlled. It may be an option if you have heart or blood vessel disease, or are at high risk for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have heart or blood vessel disease
- You are 55 or older and are at high risk for heart disease
- Your blood pressure is not controlled despite taking at least 2 blood pressure medicines, including a water pill (thiazide or similar diuretic)
- You do not have another cause for your high blood pressure (like kidney or hormone problems)
- You do not have severely low blood pressure when standing up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called clazakizumab to see if it can reduce the risk of heart attacks, strokes, or cardiovascular death in people with high inflammation and certain chronic conditions like heart disease, diabetes, or kidney disease. Participation may help researchers learn if this treatment is safe and effective for this population.
This study tests a new experimental drug called ALN-AGT01 RVR in people with mild to moderate high blood pressure. The drug may help lower blood pressure by targeting a protein in the body that regulates blood pressure.
This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.
This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.
This trial tests if iloperidone can lower blood pressure in people whose high blood pressure is not controlled by current medications. You may qualify if your blood pressure is still high after weeks of treatment.
This trial tests if the weight loss medication tirzepatide can help young adults (18–40) with obesity and high blood pressure lower their blood pressure. It compares standard care to weight loss with tirzepatide.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.